Long‐term colestyramine treatment prevents cholestatic attacks in refractory benign recurrent intrahepatic cholestasis type 1 disease
2021 ◽
Vol 19
(4)
◽
pp. 462-467
2020 ◽
Vol Publish Ahead of Print
◽
2012 ◽
Vol 47
(4)
◽
pp. 482-488
◽